MedTrace Logo

STARZ-TX2 Clinical Study: Study of Thoracic Aortic Aneurysm Repair With the Zenith TX2 Endovascular Graft

NCT00111176 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 260

Last updated 2014-08-18

No results posted yet for this study

Summary

The STARZ-TX2 trial (Study of Thoracic Aortic Aneurysm Repair with the Zenith TX2(R) TAA \[Thoracic Aortic Aneurysm\] Endovascular Graft) is a clinical trial approved by the United States Food and Drug Administration (FDA) to study the safety and effectiveness of the Zenith TX2 TAA Endovascular Graft in the treatment of thoracic aortic aneurysms / ulcers.

Conditions

  • Thoracic Aortic Aneurysm

Interventions

DEVICE

Endovascular repair

Endovascular repair.

PROCEDURE

Surgical

Surgical endovascular repair

Sponsors & Collaborators

  • William Cook Europe

    collaborator INDUSTRY

  • William Cook Australia

    collaborator INDUSTRY

  • MED Institute, Incorporated

    collaborator INDUSTRY

  • Cook Group Incorporated

    lead INDUSTRY

Principal Investigators

  • Jon Matsumura, MD · University of Wisconsin, Madison

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-03-31
Primary Completion
2007-07-31
Completion
2013-05-31

Countries

  • United States
  • Canada
  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00111176 on ClinicalTrials.gov